Edition:
United Kingdom

People: Collegium Pharmaceutical Inc (COLL.OQ)

COLL.OQ on NASDAQ Stock Exchange Global Select Market

11.86USD
20 Aug 2019
Change (% chg)

-- (--)
Prev Close
$11.86
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
105,216
52-wk High
$19.79
52-wk Low
$10.02

Dreyer, Scott 

Mr. Scott Dreyer is Executive Vice President and Chief Commercial Officer of the company. Mr. Dreyer has served as our Executive Vice President and Chief Commercial Officer since August 2018, and joined us in January 2018 as Senior Vice President, Sales, Marketing and Training. Prior to joining us, Mr. Dreyer served as the Senior Vice President, Sales, Marketing and Commercial Operations at The Medicines Company, a biopharmaceutical company, from September 2016 to December 2017; Vice President and Chief Marketing Officer – US at Biogen from June 2014 to September 2016; and Vice President, Business Development at Publicis Touchpoint Solutions, a healthcare commercialization company, from October 2013 to June 2014. Mr. Dreyer began his career in the pharmaceutical industry at Merck & Co., where he held roles of increasing responsibility from 1994 to 2013, including Vice President of Hospital and Oncology Sales from 2011 to 2012, and Vice President of Primary Care Sales from 2012 until 2013. Mr. Dreyer holds a B.S. in Biology from Messiah College in 1994.

Basic Compensation

Total Annual Compensation, USD 356,692
Restricted Stock Award, USD 307,858
Long-Term Incentive Plans, USD --
All Other, USD 1,312,360
Fiscal Year Total, USD 1,976,910

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michael Heffernan

4,694,040

Joseph Ciaffoni

3,505,300

Paul Brannelly

1,975,500

Alison Fleming

1,909,170

Shirley Kuhlmann

1,607,030

Scott Dreyer

1,976,910
As Of  31 Dec 2018